When mice were inoculated with B16-ova tumor cells, we similarly found that mice developed significantly larger tumors when they had received an F-MuLV Env immunization 3 days before tumor cell inoculation than non-vaccinated mice, but in this tumor model, none of the mice were able to clear the tumor (Figure 4C). This evidence concerns the gene ERVW-1 and neoplasm.